Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data
Bio Expo
Champignondagen
  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
MASH
  • NewsBusiness

Vida Health Adds MASH to Cardiometabolic Care to Address Rising Obesity-Linked Costs

  • The Pharma Data
  • February 11, 2026

Vida Health Expands Cardiometabolic Care to Include MASH, Addressing a Fast-Growing Obesity-Related Cost Driver Vida Health, a virtual, personalized obesity care provider that helps patients manage obesity, diabetes, and related…

Read MoreVida Health Adds MASH to Cardiometabolic Care to Address Rising Obesity-Linked Costs
Humira
  • News

MedImpact Offers Humira Biosimilar at 95% Discount to Hospitals and Pharmacies

  • The Pharma Data
  • February 11, 2026

MedImpact Offers Humira Biosimilar 95% Below the Cost of Humira to Any Hospital or Pharmacy MedImpact Holdings, Inc. today announced the launch of an unbranded biosimilar to Humira® (adalimumab) priced…

Read MoreMedImpact Offers Humira Biosimilar at 95% Discount to Hospitals and Pharmacies
Planet
  • BusinessNews

VideaHealth and Aspen Dental Execute Major AI Rollout to Elevate Dental Care Across the U.S.

  • The Pharma Data
  • February 11, 2026

VideaHealth and Aspen Dental Launch One of Dentistry’s Largest AI Rollouts in Record Time, Redefining Patient Care Nationwide VideaHealth, the leading dental AI platform, and Aspen Dental Management, Inc., one…

Read MoreVideaHealth and Aspen Dental Execute Major AI Rollout to Elevate Dental Care Across the U.S.
HemoSonics’
  • Press Releases

HemoSonics’ Quantra System Selected as 2026 Edison Awards Finalist for Obstetric Care

  • The Pharma Data
  • February 11, 2026

HemoSonics’ Quantra Hemostasis System for Obstetric Procedures Named a 2026 Edison Awards Finalist HemoSonics LLC, a medical device company focused on acute bleeding management, today announced that its Quantra® Hemostasis System for…

Read MoreHemoSonics’ Quantra System Selected as 2026 Edison Awards Finalist for Obstetric Care
GovRAMP
  • News

Butterfly Network Earns GovRAMP and TX-RAMP Information Security Certifications

  • The Pharma Data
  • February 11, 2026

Butterfly Network Achieves GovRAMP and TX-RAMP Information Security Certifications Butterfly Network, Inc. a digital health company transforming care with semiconductor chip-based ultrasound devices, software and AI, today announced that its…

Read MoreButterfly Network Earns GovRAMP and TX-RAMP Information Security Certifications
Coya Therapeutics
  • News

Coya Therapeutics Schedules Webinar with Medical Experts on ALS Research and Clinical Progress

  • The Pharma Data
  • February 11, 2026

Coya Therapeutics to Host Webinar with Leading Medical Experts on Amyotrophic Lateral Sclerosis (ALS) Drug Development, Patient Landscape, and Ongoing Clinical Trial Coya Therapeutics, Inc a clinical-stage biotechnology company developing…

Read MoreCoya Therapeutics Schedules Webinar with Medical Experts on ALS Research and Clinical Progress
Innovate
  • News

Innovate 32 Teams Up with Trivette Osborne & Associates to Grow Tennessee Dental Presence

  • The Pharma Data
  • February 11, 2026

Innovate 32 Partners with Trivette Osborne & Associates, Expanding its Dental Services Presence in Tennessee Innovate 32 a rapidly expanding, partner-driven dental services organization, announced its partnership with Trivette Osborne…

Read MoreInnovate 32 Teams Up with Trivette Osborne & Associates to Grow Tennessee Dental Presence
NextPoint
  • Press Releases

NextPoint Therapeutics Announces Clinical Debut of Novel NPX372 for Solid Tumor Treatment

  • The Pharma Data
  • February 10, 2026

NextPoint Therapeutics Announces Clinical Entry of NPX372, a First-in-Class B7-H7–Targeted T Cell Engager to Treat Solid Tumors NextPoint Therapeutics, a clinical-stage biotechnology company developing a new world of precision therapeutics…

Read MoreNextPoint Therapeutics Announces Clinical Debut of Novel NPX372 for Solid Tumor Treatment
Nuvation
  • Press Releases

Nuvation Bio Launches Global Phase 3 SIGMA Trial of Safusidenib for IDH1-Mutant Glioma

  • The Pharma Data
  • February 10, 2026

Nuvation Bio Announces Pivotal Global Phase 3 SIGMA Trial (G203) for Safusidenib in IDH1-Mutant Glioma Nuvation Bio Inc. a global oncology company focused on tackling some of the toughest challenges in…

Read MoreNuvation Bio Launches Global Phase 3 SIGMA Trial of Safusidenib for IDH1-Mutant Glioma
GE HealthCare
  • Business

GE HealthCare Unveils ReadyFix Solution to Boost Efficiency and Care Delivery

  • The Pharma Data
  • February 10, 2026

GE HealthCare launches ReadyFix fleet management solution to help enhance operational efficiency and reliable patient care GE HealthCare today announced the United States launch of ReadyFix™, a remote fleet management…

Read MoreGE HealthCare Unveils ReadyFix Solution to Boost Efficiency and Care Delivery
bioAffinity
  • Featured

bioAffinity Technologies Names Leading Pulmonary and Lung Cancer Experts to Advisory Board

  • The Pharma Data
  • February 10, 2026

bioAffinity Technologies Appoints Nationally Recognized Pulmonary and Lung Cancer Authorities to its Medical and Scientific Advisory Board bioAffinity Technologies, Inc. a biotechnology company focused on noninvasive diagnostics and early cancer detection,…

Read MorebioAffinity Technologies Names Leading Pulmonary and Lung Cancer Experts to Advisory Board
Immunopharma
  • News

Estrella Immunopharma Showcases Updated EB103 Data at 2026 ASTCT® & CIBMTR® Tandem Meetings

  • The Pharma Data
  • February 10, 2026

Estrella Immunopharma Presents Promising Updated Data on EB103 in Oral Presentation at the 2026 Tandem Meetings of ASTCT® & CIBMTR® Estrella Immunopharma, Inc. (Nasdaq: ESLA, ESLAW) a clinical-stage biopharmaceutical company developing…

Read MoreEstrella Immunopharma Showcases Updated EB103 Data at 2026 ASTCT® & CIBMTR® Tandem Meetings
PrevNext
UK Biotech Day
Global Clinical
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • Curi Bio and Battelle Partner to Advance Neuromuscular Pharmacology Innovations
  • ImmunityBio Secures Macau Approval for ANKTIVA® to Treat BCG-Unresponsive NMIBC with CIS With or Without Papillary Tumors
  • KalVista to Showcase New EKTERLY® Data at 2026 Global Angioedema Conference
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.